about
A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated LiposomesThe anti-membranous glomerulonephritic activity of purified polysaccharides from Irpex lacteus Fr.Liquiritin modulates ERK‑ and AKT/GSK‑3β‑dependent pathways to protect against glutamate‑induced cell damage in differentiated PC12 cells.Involvement of the ERK pathway in the protective effects of glycyrrhizic acid against the MPP+-induced apoptosis of dopaminergic neuronal cells.ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells.Near infrared spectroscopic (NIRS) analysis of drug-loading rate and particle size of risperidone microspheres by improved chemometric model.Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.Liquiritigenin induces tumor cell death through mitogen-activated protein kinase- (MPAKs-) mediated pathway in hepatocellular carcinoma cellsNanotechnology for the delivery of phytochemicals in cancer therapy.Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.Fatty acid modified octa-arginine for delivery of siRNA.Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel.A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.Lipid nanoparticles for hepatic delivery of small interfering RNA.Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.Near infrared spectroscopy coupled with radial basis function neural network for at-line monitoring of Lactococcus lactis subsp. fermentation.A polyethylenimine-linoleic acid conjugate for antisense oligonucleotide deliveryParenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents.Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery.Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH.Preparation of a mixed-matrix hydrogel of vorinostat for topical administration on the rats as experimental model.Anti-diabetic activities of Paecilomyces tenuipes N45 extract in alloxan-induced diabetic mice.Protective roles of Amanita caesarea polysaccharides against Alzheimer's disease via Nrf2 pathwayLiposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapyTargeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed MicellesA novel reduction-sensitive modified polyethylenimine oligonucleotide vectorDual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritisTrastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer TherapyCell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of GliomaFolate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver CabazitaxelSarcodon imbricatus polysaccharides protect against cyclophosphamide-induced immunosuppression via regulating Nrf2-mediated oxidative stressLiposomal Vitamin D3 as an Anti-aging Agent for the SkinAnti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal ApplicationsLarge-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporationNanotechnology and Microtechnology in Drug Delivery Systems
P50
Q28547510-5E118AD0-3176-4FC1-B663-380997D9AE61Q31031591-32D91EE9-6B6C-4568-B60B-D0C5654B9419Q33891003-A8691E33-43F6-47B0-850D-7D51CCDE3362Q34000309-82B2F738-C9A7-4361-B884-A57269629CC3Q34083557-CDC27501-95BB-4A4A-96BB-E884E580436BQ35193042-DD0CCC74-0210-4A10-B3A3-929147C67398Q36372323-878F39D2-7DB1-461A-8C26-9BACD7DF705AQ37668220-967D1EB0-43EE-422D-A247-3298DCD1BE09Q38806448-E2788766-C09C-4103-97D7-DD95710C16E3Q38815920-FBA0B105-1C1D-4DA9-BC42-CFE9AFC2135CQ38834154-CC4C583F-ADDB-4C88-9634-983DA0B7FD13Q38844509-DDBFA790-56B2-4313-8CA3-B2C2A379753CQ38933956-63F09754-6D41-4F20-988D-19E661E7368FQ38977151-22BE8F97-89BD-4B2D-A58E-BAC072885C4FQ39003380-28F3E2FD-27CD-40E6-BD09-BEC3DC42DDC4Q39339170-5F001062-835F-405E-9D1B-790FAC43E469Q40133415-BC3AA60F-0B5E-41CF-9C1F-E55A05F0C773Q40376534-C1564E13-C822-4AE7-9542-13A480A55A30Q41823627-03EF29D2-F8CA-47BF-A69E-4485D8D7D7E0Q41876243-8F1AA38B-AA94-48AD-A9FC-3DE001CB3BC5Q44418991-0F7A7F08-8B11-47B3-B0F5-808498083E86Q45900389-F631E7FA-05FA-4517-80FC-FEC11992DA49Q48190879-D92D4CF1-732D-47A8-ADD4-9082BE757508Q51373347-DCAD9EA7-E455-4AA0-A6DB-8CB6CD802B50Q51690166-74396CED-8254-46D0-9BD5-754B19A7B6B9Q53389716-B61C0DA9-FF08-4251-8495-82049E265296Q53644835-BB3DC94C-C36E-427F-BE41-2AF488D181D3Q57046435-8EF598AB-2EC9-47F1-BFD4-AD0820293BC5Q57483736-C121A9DF-5136-43C4-A9EC-CE5AC4C40366Q64121069-109016F4-A1A6-4BFC-BEA0-5AB97EE80F5BQ86777618-33526598-FC30-4026-B278-FE3E8F71B21AQ89179104-06D72EE7-E3D6-4B24-8FC6-B86067CFE9F3Q90115421-8C495C12-9E19-4177-B07B-89016C1D78E5Q90418931-AE7AE295-920D-4DF8-895E-B3098C30E4D5Q90774239-1341DBD1-FDEC-4994-BE38-E173D63D7E2BQ91257162-F8012012-99FB-4903-A50D-D1DB58C18A33Q91656311-EB7BFB9D-3E2B-4FA7-A123-C0202EF06644Q91828010-E07EE574-AD60-4741-800E-0781E4A5E0B4Q92025072-F5A6790A-402A-4A40-BA28-8A87B0D21D28Q92098857-25D8703F-79D8-4004-B881-C92D03A88215
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lesheng Teng
@ast
Lesheng Teng
@en
Lesheng Teng
@es
Lesheng Teng
@nl
Lesheng Teng
@sl
type
label
Lesheng Teng
@ast
Lesheng Teng
@en
Lesheng Teng
@es
Lesheng Teng
@nl
Lesheng Teng
@sl
prefLabel
Lesheng Teng
@ast
Lesheng Teng
@en
Lesheng Teng
@es
Lesheng Teng
@nl
Lesheng Teng
@sl
P106
P108
P1153
24768080500
P31
P496
0000-0003-1623-5384